RITONAVIR VIATRIS 100 mg, film-coated tablet 30 tablets
Active ingredients: Ritonavir
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
Out of stock
Package details
Original BDPM fields are shown in French.
- Official name
- RITONAVIR VIATRIS 100 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS (IRLANDE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jul 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61578339CIP73012237CIP133400930122372Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RITONAVIRcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.